[A feasibility study of the EMO scoring system to guide proximal tibial transverse transport in treatment of diabetic foot wounds].

Q3 Medicine
Wenhao Liu, Jianyang Shan, Mingming Zhu, Gen Wen, Liang Cheng
{"title":"[A feasibility study of the EMO scoring system to guide proximal tibial transverse transport in treatment of diabetic foot wounds].","authors":"Wenhao Liu, Jianyang Shan, Mingming Zhu, Gen Wen, Liang Cheng","doi":"10.7507/1002-1892.202410054","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The self-defined multidisciplinary (endocrinology, vascular surgery, and orthopedics) scoring system (EMO scoring system for short) was designed. The feasibility of the EMO scoring system to guide the proximal tibial transverse transport (TTT) for diabetic foot wounds was preliminarily explored.</p><p><strong>Methods: </strong>Based on the current commonly used clinical criteria for diabetic foot judgment, expert consensus, guidelines, and related research progress in the treatment of diabetic foot wounds, combined with clinical experience, a set of EMO scoring systems including endocrinology, vascular surgery, and orthopedics was formulated. The criteria for selecting conservative treatment, TTT after baseline improvement, and TTT based on scoring results was proposed. A total of 56 patients with diabetic foot wounds who were admitted between September 2017 and July 2022 and met the selection criteria was taken as the study subjects. Among them, 28 patients were treated with TTT and 28 patients were treated conservatively. The patients were graded according to the EMO scoring system, the corresponding treatment methods were selected, and the actual treatment methods and results of the patients were compared.</p><p><strong>Results: </strong>The EMO scoring system was formed through literature retrieval and clinical experiences. The system included three criteria, namely endocrinology (E), macrovascular disease (M), and orthopedics (O), which were divided into multiple subtypes according to the relevant evaluation items, and finally the diabetic foot wound was divided into 8 types, which correspondingly selected TTT, TTT after baseline improvement, and conservative treatment. All 56 patients were followed up 12 months after treatment. Among them, the wound healing rate of the TTT group was 85.71% (24/28), which was higher than that of the conservative treatment group [53.57% (15/28)]. At 12 week after treatment, CT angiography showed that there were more small blood vessels in the wound and ipsilateral limb in TTT group than in the conservative treatment group. Based on the EMO scoring system, 14 of the 56 patients needed conservative treatment, 29 patients needed TTT, and 13 patients needed TTT after baseline improvement. Compared with the clinical data of the patients, the wound healing rate of the patients judged to be TTT was 75.86% (22/29), of which 21 cases were actually treated with TTT, and the healing rate was 90.48%; 8 patients were treated conservatively, and the healing rate was 37.50%. The wound healing rate of the patients judged to be conservative treatment was 92.86% (13/14), of which 1 case was actually treated with TTT, and the healing rate was 100%; 13 cases were treated conservatively, and the healing rate was 92.31%; 1 case experienced minor amputation. The wound healing rate of the patients judged to TTT after baseline improvement was only 30.77% (4/13), of which 6 cases were actually treated with TTT, and the healing rate was 66.67%; 7 cases were treated conservatively, and the healing rate was 0.</p><p><strong>Conclusion: </strong>EMO scoring system can comprehensively evaluate the diabetic foot wounds, and make personalized judgment on whether TTT treatment is feasible, so as to improve the level of diabetic foot wound treatment and the prognosis of patients.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"39 3","pages":"326-331"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11919509/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国修复重建外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7507/1002-1892.202410054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The self-defined multidisciplinary (endocrinology, vascular surgery, and orthopedics) scoring system (EMO scoring system for short) was designed. The feasibility of the EMO scoring system to guide the proximal tibial transverse transport (TTT) for diabetic foot wounds was preliminarily explored.

Methods: Based on the current commonly used clinical criteria for diabetic foot judgment, expert consensus, guidelines, and related research progress in the treatment of diabetic foot wounds, combined with clinical experience, a set of EMO scoring systems including endocrinology, vascular surgery, and orthopedics was formulated. The criteria for selecting conservative treatment, TTT after baseline improvement, and TTT based on scoring results was proposed. A total of 56 patients with diabetic foot wounds who were admitted between September 2017 and July 2022 and met the selection criteria was taken as the study subjects. Among them, 28 patients were treated with TTT and 28 patients were treated conservatively. The patients were graded according to the EMO scoring system, the corresponding treatment methods were selected, and the actual treatment methods and results of the patients were compared.

Results: The EMO scoring system was formed through literature retrieval and clinical experiences. The system included three criteria, namely endocrinology (E), macrovascular disease (M), and orthopedics (O), which were divided into multiple subtypes according to the relevant evaluation items, and finally the diabetic foot wound was divided into 8 types, which correspondingly selected TTT, TTT after baseline improvement, and conservative treatment. All 56 patients were followed up 12 months after treatment. Among them, the wound healing rate of the TTT group was 85.71% (24/28), which was higher than that of the conservative treatment group [53.57% (15/28)]. At 12 week after treatment, CT angiography showed that there were more small blood vessels in the wound and ipsilateral limb in TTT group than in the conservative treatment group. Based on the EMO scoring system, 14 of the 56 patients needed conservative treatment, 29 patients needed TTT, and 13 patients needed TTT after baseline improvement. Compared with the clinical data of the patients, the wound healing rate of the patients judged to be TTT was 75.86% (22/29), of which 21 cases were actually treated with TTT, and the healing rate was 90.48%; 8 patients were treated conservatively, and the healing rate was 37.50%. The wound healing rate of the patients judged to be conservative treatment was 92.86% (13/14), of which 1 case was actually treated with TTT, and the healing rate was 100%; 13 cases were treated conservatively, and the healing rate was 92.31%; 1 case experienced minor amputation. The wound healing rate of the patients judged to TTT after baseline improvement was only 30.77% (4/13), of which 6 cases were actually treated with TTT, and the healing rate was 66.67%; 7 cases were treated conservatively, and the healing rate was 0.

Conclusion: EMO scoring system can comprehensively evaluate the diabetic foot wounds, and make personalized judgment on whether TTT treatment is feasible, so as to improve the level of diabetic foot wound treatment and the prognosis of patients.

[EMO评分系统引导胫骨近端横向运输治疗糖尿病足创伤的可行性研究]。
目的:设计自定义多学科(内分泌、血管外科、骨科)评分系统(简称EMO评分系统)。初步探讨EMO评分系统指导糖尿病足创伤胫骨近端横向转运(TTT)的可行性。方法:根据目前临床常用的糖尿病足判断标准、专家共识、指南以及糖尿病足创面治疗的相关研究进展,结合临床经验,制定一套包括内分泌科、血管外科、骨科在内的EMO评分系统。提出保守治疗、基线改善后TTT、评分结果TTT的选择标准。选取2017年9月至2022年7月收治的56例符合入选标准的糖尿病足外伤患者作为研究对象。其中TTT治疗28例,保守治疗28例。根据EMO评分系统对患者进行评分,选择相应的治疗方法,并对患者的实际治疗方法和结果进行比较。结果:通过文献检索和临床经验,形成EMO评分体系。该系统包括内分泌科(E)、大血管病(M)、骨科(O) 3个标准,根据相关评价项目分为多个亚型,最终将糖尿病足创面分为8个类型,相应选择TTT、基线改善后TTT、保守治疗。56例患者均在治疗后12个月随访。其中,TTT组创面愈合率为85.71%(24/28),高于保守治疗组的53.57%(15/28)。治疗12周后CT血管造影显示TTT组创面及同侧肢体小血管较保守治疗组多。根据EMO评分系统,56例患者中14例需要保守治疗,29例需要TTT治疗,基线改善后13例需要TTT治疗。与患者临床资料比较,判断为TTT的患者创面愈合率为75.86%(22/29),其中实际应用TTT治疗的21例,愈合率为90.48%;保守治疗8例,治愈率为37.50%。判定保守治疗的患者创面愈合率为92.86%(13/14),其中实际应用TTT治疗1例,治愈率为100%;保守治疗13例,治愈率92.31%;1例轻度截肢。基线改善后判断为TTT的患者创面愈合率仅为30.77%(4/13),其中实际应用TTT治疗的6例,愈合率为66.67%;保守治疗7例,治愈率0。结论:EMO评分系统可以对糖尿病足创伤进行综合评价,对TTT治疗是否可行做出个性化判断,从而提高糖尿病足创伤治疗水平,改善患者预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中国修复重建外科杂志
中国修复重建外科杂志 Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
11334
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信